Harnessing PD-L1-specific cytotoxic T cells for anti-leukemia immunotherapy to defeat mechanisms of immune escape mediated by the PD-1 pathway

被引：37

作者：

Ahmad, S. M. ^{[1
]}

Larsen, S. K. ^{[1
]}

Svane, I. M. ^{[1
]}

Andersen, M. H. ^{[1
]}

机构：

[1] Copenhagen Univ Hosp, CCIT, Dept Hematol & Oncol, Herlev, Denmark

来源：

LEUKEMIA | 2014年 / 28卷 / 01期

关键词：

B7; FAMILY; EXPRESSION; B7-H1; CLL;

D O I：

10.1038/leu.2013.261

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：236 / 238

页数：4

共 15 条

[1] Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells [J].

Ame-Thomas, P. ;

Le Priol, J. ;

Yssel, H. ;

Caron, G. ;

Pangault, C. ;

Jean, R. ;

Martin, N. ;

Marafioti, T. ;

Gaulard, P. ;

Lamy, T. ;

Fest, T. ;

Semana, G. ;

Tarte, K. .

LEUKEMIA, 2012, 26 (05) :1053-1063

[2] PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies [J].

Chen, Benjamin J. ;

Chapuy, Bjoern ;

Jing Ouyang ;

Sun, Heather H. ;

Roemer, Margaretha G. M. ;

Xu, Mina L. ;

Yu, Hongbo ;

Fletcher, Christopher D. M. ;

Freeman, Gordon J. ;

Shipp, Margaret A. ;

Rodig, Scott J. .

CLINICAL CANCER RESEARCH, 2013, 19 (13) :3462-3473

[3]

Dong HD, 1999, NAT MED, V5, P1365

[4] The role of B7 family molecules in hematologic malignancy [J].

Greaves, Paul ;

Gribben, John G. .

BLOOD, 2013, 121 (05) :734-744

[5] Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL) [J].

Hatta, Y ;

Koeffler, HP .

LEUKEMIA, 2002, 16 (06) :1069-1085

[6] Evidence for involvement of clonally expanded CD8+ T cells in anticancer immune responses in CLL patients following nonmyeloablative conditioning and hematopoietic cell transplantation [J].

Kollgaard, T ;

Petersen, SL ;

Hadrup, SR ;

Masmas, TN ;

Seremet, T ;

Andersen, MH ;

Madsen, HO ;

Vindelov, L ;

Straten, PT .

LEUKEMIA, 2005, 19 (12) :2273-2280

[7] PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients [J].

Kozako, T. ;

Yoshimitsu, M. ;

Fujiwara, H. ;

Masamoto, I. ;

Horai, S. ;

White, Y. ;

Akimoto, M. ;

Suzuki, S. ;

Matsushita, K. ;

Uozumi, K. ;

Tei, C. ;

Arima, N. .

LEUKEMIA, 2009, 23 (02) :375-382

[8] Regulatory T cells and immunodeficiency in mycosis fungoides and Sezary syndrome [J].

Krejsgaard, T. ;

Odum, N. ;

Geisler, C. ;

Wasik, M. A. ;

Woetmann, A. .

LEUKEMIA, 2012, 26 (03) :424-432

[9] Redirection of CMV-specific CTL towards B-CLL via CD20-targeted HLA/CMV complexes [J].

Mous, R. ;

Savage, P. ;

Remmerswaal, E. B. M. ;

van Lier, R. A. W. ;

Eldering, E. ;

van Oers, M. H. J. .

LEUKEMIA, 2006, 20 (06) :1096-1102

[10] Cutaneous T cell lymphoma cells are targets for immune checkpoint ligand PD-L1-specific, cytotoxic T cells [J].

Munir, S. ;

Andersen, G. H. ;

Woetmann, A. ;

Odum, N. ;

Becker, J. C. ;

Andersen, M. H. .

LEUKEMIA, 2013, 27 (11) :2251-2253

← 1 2 →